How is the ImmunityBio Inc today?

The ImmunityBio Inc today is trading in the green, up by 6.36% at 2.51.

How has ImmunityBio Inc performed historically?

The ImmunityBio Inc is currently trading up 6.36% on an intraday basis in the past week the index rose 19.52%. The index has been down -22.53% in the past quarter and fell -69.09% in the past year. You can view this in the overview section.

What is ImmunityBio Inc Annual Revenue?

ImmunityBio Inc Annual Revenue rose 2,270.58%, in the last year to $14.74 M. Its sector's average revenue growth for the last fiscal year was 8.63%.

What is ImmunityBio Inc Annual Net Profit?

ImmunityBio Inc Annual Net Profit rose 29.09% in the last year to $413.56 M. Its sector's average net profit growth for the last fiscal year was -7.19%.

What is ImmunityBio Inc Price to Earning Ratio?

ImmunityBio Inc Price to Earning Ratio is -5.36, which is negative.

What is ImmunityBio Inc Stock Price?

ImmunityBio Inc Stock Price fell 69.09% and underperformed its sector by 74.65% in the past year.

What is ImmunityBio Inc Quarterly Revenue?

ImmunityBio Inc Quarterly Revenue rose 5,333.09% YoY to $7.55 M. Its sector's average revenue growth YoY for the quarter was 2.8%.

What is ImmunityBio Inc Quarterly Net profit?

ImmunityBio Inc Quarterly Net profit rose 74.65% YoY to $59.16 M. Its sector's average net profit growth YoY for the quarter was -210.52%.

What is ImmunityBio Inc Mutual Fund Holding?

ImmunityBio Inc Mutual Fund Holding decreased by 0.35% in the last quarter to 6.82.

What is ImmunityBio Inc Interest Coverage Ratio?

ImmunityBio Inc Interest Coverage Ratio is -2.14, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is ImmunityBio Inc Institutional Holding?

ImmunityBio Inc Institutional Holding increased by 0.01% in the last quarter to 9.69.

ImmunityBio Inc XNAS: IBRX

ImmunityBio Inc Live Share Price Today, Share Analysis and Chart

Name: ImmunityBio Inc: Is Infosys Ltd. worth buying?
Item: ImmunityBio Inc
Rating: 0.82941675
Author: Trendlyne DVM scores

about

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...

2.51 0.15 (6.36%)

New 52W Low in past week

14.8M XNAS Volume

XNAS 13 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for ImmunityBio Inc is on 16 May 2025 for the purpose of ImmunityBio Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

1.2 / 100

Technically Bearish

32.0 / 100

1Yr Price target upside is 418%

4 analysts

ImmunityBio Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ImmunityBio Inc Live Share Price Today, Share Analysis and Chart

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...

New 52W Low in past week

SWOT Analysis

ImmunityBio Inc Live Price Chart

ImmunityBio Inc FAQ

How is ImmunityBio Inc today?

ImmunityBio Inc today is trading in the green, and is up by 6.36% at 2.51.

How has ImmunityBio Inc performed historically?

ImmunityBio Inc is currently trading up 6.36% on an intraday basis. In the past week the stock rose 19.52%. stock has been down -22.53% in the past quarter and fell -69.09% in the past year. You can view this in the overview section.